Clinical Trial Update: A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia [Phase 1]

View source ↗

Summary

This clinical trial update summarizes a Phase 1 study of ASP6981 in schizophrenia, evaluating safety, tolerability, pharmacodynamics, and pharmacokinetics; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ASP6981 (ASP6981)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Schizophrenia | Phase 1 | Status: COMPLETED